Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies
- 10 May 2007
- journal article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 83 (5) , 365-368
- https://doi.org/10.1136/sti.2007.024794
Abstract
Bacterial vaginosis (BV) and Herpes simplex virus type-2 (HSV-2) have been linked to an increased risk of HIV-1 acquisition. Recent research suggests an association between BV and HSV-2 acquisition, but the converse has not been studied. Here, we investigate whether an association exists between BV and HSV-2 infection We examined the determinants of BV occurrence in a cohort of female sex workers in Burkina Faso. Participants were followed every 3 months for diagnosis of genital infections and report of sexual behaviours. Factors associated with BV occurrence were assessed using generalised estimating equation models. We enrolled 273 women (mean age, 28 years) and conducted 812 follow-up visits (mean 2.93 visit per woman). Baseline seroprevalence of HIV-1, HSV-2 and recent syphilis were 31.5%, 70.1% and 0.4%, respectively, while baseline prevalence of BV, Trichomonas vaginalis (TV) and Candida albicans were 20.5%, 3.3% and 2.5%, respectively. In multivariable analysis, HSV-2 (relative risk (RR) = 1.73, 95% CI 1.12 to 2.65), HIV-1 (RR = 1.76, 95% CI 1.30 to 2.40), TV (RR = 1.5, 95% CI 1.0 to 2.3), and having > or = 3 sexual partners in the preceding week (RR = 2.2, 95% CI 1.1 to 4.6) were independently associated with BV, while hormonal contraception showed a protective effect (RR = 0.11, 95% CI 0.02 to 0.70). HSV-2 infection was associated with BV occurrence in this population. As HSV-2 is strongly linked to HIV-1 acquisition, studies assessing the cofactor effect of BV on HIV acquisition should control for the presence of HSV-2. Further studies are required to investigate the relative effect of asymptomatic HSV-2 shedding and/or genital ulcerations on BV occurrence.Keywords
This publication has 20 references indexed in Scilit:
- Bacterial Vaginosis: Risk Factors Among Kenyan Women and Their Male PartnersSexually Transmitted Diseases, 2006
- Performance of Commercially Available Enzyme Immunoassays for Detection of Antibodies against Herpes Simplex Virus Type 2 in African PopulationsJournal of Clinical Microbiology, 2004
- Monthly Antibiotic Chemoprophylaxis and Incidence of Sexually Transmitted Infections and HIV-1 Infection in Kenyan Sex WorkersJAMA, 2004
- Review of STI and HIV epidemiological data from 1990 to 2001 in urban Burkina Faso: implications for STI and HIV controlSexually Transmitted Infections, 2004
- Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial VaginosisClinical Infectious Diseases, 2003
- Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, UgandaAmerican Journal of Obstetrics and Gynecology, 2001
- Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective studyAmerican Journal of Obstetrics and Gynecology, 2001
- Serological diagnosis of human immuno-deficiency virus in Burkina Faso: reliable, practical strategies using less expensive commercial test kits.1999
- Tackling bacterial vaginosis and HIV in developing countriesThe Lancet, 1997
- Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivationMicrobial Pathogenesis, 1993